Mirum Pharmaceuticals Inc (MIRM) — Financial Flexibility Index
Mirum Pharmaceuticals Inc (MIRM) has a Financial Flexibility Index of -0.35x as of March 2026. Free cash flow of $-228.10 Million (operating CF $-228.76 Million minus capex $664.00K) represents 0% of total liabilities ($648.42 Million). Also explore how fast is Mirum Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mirum Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Mirum Pharmaceuticals Inc across 8 annual periods. Check Mirum Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Mirum Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Mirum Pharmaceuticals Inc. For the full company profile including market capitalisation, see MIRM market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | $56.78 Million | $55.83 Million | $528.12 Million | ▲ +322.8% |
| 2024 | 0.03x | $11.32 Million | $10.32 Million | $445.11 Million | ▲ +119.9% |
| 2023 | -0.13x | $-50.84 Million | $-70.94 Million | $397.95 Million | ▲ +77.5% |
| 2022 | -0.57x | $-119.86 Million | $-120.14 Million | $210.87 Million | ▲ +12.8% |
| 2021 | -0.65x | $-113.73 Million | $-132.76 Million | $174.44 Million | ▲ +49.5% |
| 2020 | -1.29x | $-88.85 Million | $-89.08 Million | $68.77 Million | ▲ +45.9% |
| 2019 | -2.39x | $-39.08 Million | $-39.36 Million | $16.36 Million | ▼ -2187.7% |
| 2018 | 0.11x | $7.13 Million | $-373.00K | $62.30 Million | — |